Bristol-Myers Squibb Earnings, Revenue beat In Q3

  • Investing.com
  • Stock Market News
Bristol-Myers Squibb Earnings, Revenue beat In Q3
Credit: © Reuters.

Investing.com - Bristol-Myers Squibb (NYSE: BMY ) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Bristol-Myers Squibb announced earnings per share of $1.99 on revenue of $11.22. Analysts polled by Investing.com anticipated EPS of $1.82 on revenue of $11.15B.

Bristol-Myers Squibb shares are up 16% from the beginning of the year and are trading at $72.77 , down-from-52-week-high.

Bristol-Myers Squibb follows other major Healthcare sector earnings this month

Bristol-Myers Squibb's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100